AGS cells are derived from the gastric tissue of a 54-year-old female, and represent one of the major players in the field of genomics research in gastric cancer. The cells are suitable for preclinical xenografts, and are prime subjects for transfection experiments. AGS cells have been researched extensively for pharmaceutical applications of histone deacetylase inhibition in stalling the growth of gastric cancer. They can easily serve as recipients of transfected genomic material, such as siRNA, which can be used for library screenings and the development of gene therapies specific to gastric cancer.
The AGS cell line originated in 1979 from the stomach tissue of a 54-year-old Caucasian female who had been diagnosed with gastric adenocarcinoma. AGS cells are tumorigenic, hyperdiploid, and have a modal chromosome number of 49. AGS exhibits adherent cultural properties and has an epithelial morphology. The AGS cell line is a good host for the study of stomach cancer and other stomach infections using in vivo and in vitro transfection methods. An AGS Transfection Reagent to transfect AGS cells is commercially available from Altogen Biosystems , and an AGS xenograft murine model is displayed here .
Comments
Post a Comment